Lukin C L, Hein H A, Swygert T H, Gunning T C, Valek T R, Donica S K, Nelson R B, Ramsay M A
Department of Anesthesiology, Baylor University Medical Center, Dallas, TX 75246.
Anesth Analg. 1995 Mar;80(3):526-33. doi: 10.1097/00000539-199503000-00016.
The major causes of liver graft failure are acute rejection, technical failure, and primary nonfunction (PNF). This study was undertaken to determine whether delayed return of neuromuscular function correlates with allograft primary dysfunction in humans given vecuronium. Twenty-two adult patients undergoing orthotopic liver transplantation were given an initial dose of vecuronium, 0.1 mg/kg intravenously (i.v.). All patients recovered from vecuronium-induced neuromuscular block prior to explantation. No additional neuromuscular blocker was given until the liver graft was implanted and reperfused. Fifteen minutes after reperfusion another 0.1 mg/kg vecuronium was given IV and recovery time from attaining complete neuromuscular block to return of the fourth twitch of a train-of-four was recorded. Patients were divided into three groups according to postoperative liver function. Group I consisted of 17 patients with immediate normal liver graft function. Group II consisted of four patients with primary dysfunction (PDF) [peak aspartate aminotransferase (AST) and alanine aminotransferase (ALT) > 2000 U/L, prothrombin time > 16 s, and poor quality and quantity of bile within 3 days postoperatively] which eventually recovered normal function. Group III consisted of one patient with PNF (uncorrectable coagulopathy, severe metabolic acidosis, rising AST and ALT, and minimal or no bile output), whose graft never recovered. Recovery time in Groups II and III was prolonged compared to Group I (P < 0.05). Recovery time in Group III was prolonged compared to Group II (P < 0.05). A test based on these results using a recovery time of > 135 min as a predictor of PDF has a sensitivity and specificity of 80% and 76%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
肝移植失败的主要原因是急性排斥反应、技术失误和原发性无功能(PNF)。本研究旨在确定维库溴铵麻醉的人体中神经肌肉功能延迟恢复是否与同种异体肝原发性功能障碍相关。22例接受原位肝移植的成年患者静脉注射初始剂量的维库溴铵,0.1mg/kg。所有患者在肝移植前均从维库溴铵诱导的神经肌肉阻滞中恢复。在植入和再灌注肝移植之前不再给予额外的神经肌肉阻滞剂。再灌注15分钟后,静脉注射另外0.1mg/kg维库溴铵,并记录从达到完全神经肌肉阻滞到四个成串刺激中第四个颤搐恢复的时间。根据术后肝功能将患者分为三组。第一组由17例肝移植后肝功能立即恢复正常的患者组成。第二组由4例原发性功能障碍(PDF)患者组成[术后3天内天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)峰值>2000U/L,凝血酶原时间>16秒,胆汁质量和量差],最终恢复正常功能。第三组由1例PNF患者组成(无法纠正的凝血病、严重代谢性酸中毒、AST和ALT升高以及胆汁分泌极少或无胆汁分泌),其移植肝从未恢复。与第一组相比,第二组和第三组的恢复时间延长(P<0.05)。与第二组相比,第三组的恢复时间延长(P<0.05)。基于这些结果,以恢复时间>135分钟作为PDF预测指标的试验,其敏感性和特异性分别为80%和76%。(摘要截短至250字)